COVID-19 Clinical Research Center
Located on Fred Hutch's South Lake Union campus in Seattle, the COVID-19 Clinical Research Center conducts innovative studies for SARS-CoV-2-positive participants, the virus that causes COVID-19.
The COVID-19 Clinical Research Center is a standalone research facility for the conduct of phase 1-3 clinical trials to find effective treatments for SARS-CoV-2-positive study participants. The CCRC offers the opportunity for collaboration by virologists, immunologists, epidemiologist, translational and physician scientists to apply their expertise to determine safe and effective therapies in partnership with health care providers, research institutes, and the biotech/pharmaceutical industry.
This virus doesn’t discriminate, and it will take a collaborative effort of researchers, scientists, health care providers and study participants to work together in stopping this pandemic. As a treatment and prevention resource, the Clinical Research Center will incorporate a diverse population of study participants in novel intervention and therapeutic trials to help in the local and international effort to deliver cures faster.
Connect with us about volunteering for a study.
Our Community Vision
The Clinical Research Center aims to gather insights from a diverse population of volunteers in our community and to collaborate with research partners who are developing and testing novel interventions, to treat infection early and effectively.
Treatment Study Participants
The Clinical Research Center offers an opportunity for participants interested in emerging treatments and interventions that are safely administered and evaluated outside of a traditional hospital setting. The Center is seeking volunteer participants that are SARS-CoV-2-positive, both asymptomatic or mildly symptomatic.
- Our studies are inclusive of adult participants of all races, ethnicities, and backgrounds to help researchers understand the best treatment medicines and methods across diverse populations
- We provide treatment trials in a safe and secure setting designed with air flow & filtration systems that prioritize participant and staff safety
- Our research teams have a collaborative focus to test drugs and antibodies that are currently in development, second-generation therapeutics, and combinations of treatments and interventions
Commitment to Collaboration
We are seeking collaborations with area health care colleagues who share our drive to innovate, collaborate and save lives. Collaborators are needed to both identify participants and conduct clinical trials. The COVID-19 pandemic is placing a great burden on health care systems. We aim to lessen this burden by treating infection early after the development of symptoms for these reasons:
- SARS-CoV-2 infection severity is difficult to ascertain in the early stages of disease and rapidly progresses
- Ascertaining effective treatment methods that can be applied soon after diagnosis represents an ideal opportunity for limiting spread, reducing hospitalizations and death, and reopening our society
- The risk of transmission makes it difficult for standard outpatient facilities to treat people with COVID-19
About the Facility
- 6,000+ sq. ft. stand-alone building located on Fred Hutch's South Lake Union campus in Seattle, WA
- 11 private clinic rooms with windowed doors for safe monitoring and large, open nursing stations
- Separated airborne precaution and clean areas, with air flow and filtration systems that prioritize participant and staff safety
- Appropriate PPE for all CCRC staff and participants with extensive cleaning & disinfecting protocols
- Optimized navigation and separate entry/exits for study participants
- Dedicated parking for select trial participants and in some cases, car services
- Secure and restricted access to the facility
- Oversight by Medical Director Rachel A. Bender Ignacio, M.D., M.P.H.
Fred Hutch and the greater Seattle community are well-positioned to bring our scientific depth and integrity, innovative thinking, compassion for people and drive for excellence, to better understand and ultimately cure this disease.
COVID-19 Clinical Research Center Leadership
Grounded in experience with global health threats, our team is playing an important role in the international scientific response to the pandemic.
Rachel A. Bender Ignacio, M.D., M.P.H.
Fatima Ranjbaran, B.Sc., B.S.N., R.N., C.C.R.P.
Julie McElrath, M.D., Ph.D.
Larry Corey, M.D
Rachel A. Bender Ignacio, M.D., M.P.H.
Dr. Rachel Bender lgnacio serves as the Medical Director of the CCRC. In addition to overseeing a team of on-site clinical and support staff, she'll also be responsible for ensuring that the trials are conducted safely and with best clinical and scientific practices. She has overseen the scientific and operational processes for clinical trials related to COVID-19 since the start of the pandemic. Dr. Bender Ignacio is an assistant professor in the Division of Allergy & Infectious Diseases in the University of Washington Department of Medicine and an associate in the Hutch's Vaccine and Infectious Disease Division.
Support COVID-19 Research
Every dollar helps our scientists reduce the threat of the novel coronavirus.
COVID-19 Clinical Research Center
Entrance A:
820 Minor Ave N.
Seattle, WA 98109
Directions
Entrance B:
1205 Aloha St.
Seattle, WA 98109
Directions